DOCSLIB.ORG

Painful Facial Blisters, Fever, and Conjunctivitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Painful Facial Blisters, Fever, and Conjunctivitis PHOTO ROUNDS Melissa Neuman, MD; Jack Spittler, MD Painful facial blisters, fever, University of Colorado Family Medicine, Denver and conjunctivitis [email protected] DEPARTMENT EDITOR Following Tx for facial blisters, our patient returned Richard P. Usatine, MD University of Texas Health with what appeared to be viral conjunctivitis. Further at San Antonio evaluation revealed a missed tip-off to the proper Dx. The authors reported no potential conflict of interest relevant to this article. a 58-year-old woman with a history of eye, associated blurriness, and decreased vi- hepatitis C, liver cirrhosis, hepatocellular sion. She had been using a warm compress carcinoma, hypothyroidism, and peripheral on the eye and found that it was getting sticky neuropathy presented to our clinic with left and crusted. A gray corneal opacity was seen ear pain and blisters on her lips, nose, and on physical exam, and a fluorescein exam was mouth. On exam, the patient’s left tympanic performed (FIGURE). membrane was opaque, and she had mul- tiple 3- to 5-mm irregularly shaped ulcers on ● WHAT IS YOUR DIAGNOSIS? her right buccal mucosa, gingiva, and lips. She was given a diagnosis of acute otitis media and ● HOW WOULD YOU TREAT THIS prescribed a course of amoxicillin. The physi- PATIENT? cian, who was uncertain about the cause of her gingivostomatitis, took a “shotgun approach” and prescribed a nystatin/diphenhydramine/ lidocaine mouthwash. FIGURE Three weeks later, the patient returned complaining of cloudy urine, dysuria, fever, Fluorescein exam reveals large, dendritic vomiting, and “pink eye.” On exam, her right epithelial defects eye was mildly injected with no drainage. She had normal eye movements and no ophthal- moplegia. We diagnosed viral (vs allergic) con- OF: MELISSA NEUMAN, MD, AND JACK SPITTLER, MD IMAGE COURTESY junctivitis and pyelonephritis in this patient and advised her to use lubricant eyedrops and an oral antihistamine for the eye. We also started her on cefpodoxime (200 mg bid for 10 days) for pyelonephritis. Three days later, the patient called our clinic and said that her right eye was not im- proving. We prescribed ofloxacin ophthalmic drops, 1 to 2 drops every 6 hours, for presumed bacterial conjunctivitis. Four days later, she returned to our clinic; she had been using the ofloxacin drops and antihistamine but was experiencing worsen- ing symptoms, including itching of her right MDEDGE.COM/JFPONLINE VOL 67, NO 9 | SEPTEMBER 2018 | THE JOURNAL OF FAMILY PRACTICE 573 PHOTO ROUNDS Diagnosis: a mild-to-moderate iritis are signs of Herpes simplex virus keratitis endotheliitis.5 The patient was sent to the ophthalmology ❚ Neurotrophic keratopathy. This form clinic, where a slit-lamp examination of the of HSV keratitis is associated with corneal hy- right eye showed 3+ injection, large dendritic poesthesia or complete anesthesia secondary epithelial defects spanning the majority of to damage of the corneal nerves, which can the cornea (with 10% haze), and trace nuclear occur in any form of ocular HSV. Anesthesia sclerosis of the lens. These findings were con- may lead to nonhealing corneal epithelial de- sistent with a diagnosis of herpes simplex vi- fects.6 These defects, which are generally oval rus (HSV) keratitis, with a likely neurotrophic lesions, do not represent active viral disease component (decreased sensation of the af- and are made worse by antiviral drops. These fected eye compared with that of the other lesions may cause stromal scarring, corneal eye). There was no evidence of secondary perforation, or secondary bacterial infection. infection. Treatment consists of supportive care using artificial tears and prophylactic antibi- otic eye drops, if appropriate; more advanced Discussion ophthalmologic treatments may be needed for The global incidence of HSV keratitis is ap- advanced disease.7 proximately 1.5 million, including 40,000 The symptoms new cases of monocular visual impairment or Other conditions, including of HSV keratitis blindness each year.1 Primary infection with conjunctivitis, have similar symptoms include eye pain, HSV-1 occurs following direct contact with The differential for redness of the eye includes redness, blurred infected mucosa or skin surfaces and inocula- conditions such as conjunctivitis, glaucoma, vision, tearing, tion. (Our patient likely transferred the infec- and keratitis. discharge, and tion by touching her eyes after touching her ❚ Conjunctivitis of any form—bacterial, sensitivity to nose or mouth.) The virus remains in sensory viral, allergic, or toxic—involves injection of light. ganglia for the lifetime of the host. Most ocular both the palpebral and bulbar conjunctiva. disease is thought to represent recurrent HSV ❚ Acute angle closure glaucoma can in- (rather than a primary ocular infection).2 It has volve symptoms of headache, malaise, nausea, been proposed that HSV-1 latency may also and vomiting. In addition, the pupil is fixed in occur in the cornea. mid-dilation, and the cornea becomes hazy. The symptoms of HSV keratitis include ❚ Anterior uveitis/iritis causes sensitivity eye pain, redness, blurred vision, tearing, dis- to light in both the affected and unaffected charge, and sensitivity to light. eyes, as well as ciliary flush (a red ring around the iris). Typically, there is no eye discharge. The 4 diagnostic categories ❚ Bacterial keratitis causes foreign body There are 4 categories of HSV keratitis, based sensation and purulent discharge. This form of on the location of the infection: epithelial, keratitis usually occurs due to improper wear stromal, endotheliitis, and neurotrophic of contact lenses. keratopathy. ❚ Viral keratitis is characterized by pho- ❚ Epithelial. The most common form, tophobia, foreign body sensation, and watery epithelial HSV manifests as dendritic or geo- discharge. A faint branching grey opacity may graphic lesions of the cornea.3 Geographic be seen on penlight exam, and dendrites may lesions occur when a dendrite widens and be seen with fluorescein. assumes an amoeboid shape. ❚ Scleritis involves severe, boring pain of ❚ Stromal. Stromal involvement accounts the eye in addition to photophobia and head- for 20% to 25% of presentations4 and may ache. It is usually associated with systemic in- cause significant anterior chamber inflamma- flammatory disorders. tion. Vision loss can result from permanent ❚ Subconjunctival hemorrhage is as- stromal scarring.5 ymptomatic and occurs following trauma. ❚ Endotheliitis. Keratic precipitates (on ❚ Cellulitis manifests following trauma top of stromal and epithelial edema) and with a deep violet color and marked edema. 574 THE JOURNAL OF FAMILY PRACTICE | SEPTEMBER 2018 | VOL 67, NO 9 Standard Tx: this diagnosis might have prevented the ocular Antiviral medications disease, as the treatment would have been an Topical antiviral therapy is the standard treat- oral antiviral. ment for epithelial HSV keratitis, although oral ❚ If conjunctivitis is refractory to usual antiviral medications are equally effective. management, the patient must be seen to rule A randomized trial found that using an oral out dangerous eye diagnoses such as HSV agent in addition to a topical antiviral did not keratitis, preseptal or orbital cellulitis, or in the improve outcomes.8 A 2015 systematic review worst case, acute angle closure glaucoma. If found that topical antivirals acyclovir, ganci- there is uncertainty regarding diagnosis, a flu- clovir, brivudine, trifluridine were equally ef- orescein exam is helpful. This simple in-office fective in treatment outcome; 90% of patients exam can facilitate a referral to Ophthalmol- healed within 2 weeks.9 ogy or the emergency department for a slit- Recurrent ocular HSV-1 infections are lamp exam and appropriate therapy. treated in the same way as the initial infection. ❚ Our patient was started on valacyclovir Recurrent infection can be prevented with 1 g bid, trifluridine eyedrops (5×/d), and eryth- daily suppressive therapy. In one study, pa- romycin ophthalmic ointment (3×/d), with tients who took suppressive therapy (acyclovir Ophthalmology follow-up in 1 week. JFP 400 mg bid) for 1 year had 19% recurrence of CORRESPONDENCE ocular infection vs 32% in the placebo group.10 John Spittler, MD, 3055 Roslyn St, Suite 100, Denver, CO ❚ Prompt Tx is key. If the infection is su- 80238; [email protected] It’s always perficial—involving only the outer layer of better to the cornea (epithelium)—the eye should heal consider a REFERENCES without scarring with proper treatment. How- 1. Farooq AV, Shukla D. Herpes simplex epithelial and stromal kera- diagnosis of ever, if the infection is not promptly treated or titis: an epidemiologic update. Surv Ophthalmol. 2012;57:448- primary oral HSV 462. if deeper layers are involved, scarring of the 2. Holland EJ, Mahanti RL, Belongia EA, et al. Ocular involve- infection than cornea may occur. This can lead to vision loss ment in an outbreak of herpes gladiatorum. Am J Ophthalmol. to treat candida 1992;114:680-684. or blindness. 3. Cook SD. Herpes simplex virus in the eye. Br J Ophthalmol. and pain 1992;76:365-366. with a mixed 4. Liesegang TJ. Herpes simplex virus epidemiology and ocular im- A missed opportunity portance. Cornea. 2001;20:1-13. medication for an earlier diagnosis 5. Sekar Babu M, Balammal G, Sangeetha G, et al. A review on viral mouthwash. This case highlights the importance of con- keratitis caused by herpes simplex virus. J Sci. 2011;1:1-10. 6. Hamrah P, Cruzat A, Dastjerdi MH, et al. Corneal sensation ducting a thorough exam to identify findings and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology. that could shift the diagnosis from a simple 2010;117:1930-1936. allergic, viral, or bacterial conjunctivitis. It is 7. Bonini S, Rama P, Olzi D, et al. Neurotrophic keratitis. Eye. always better to consider primary oral HSV 2003;17:989-995. 8. Szentmáry N, Módis L, Imre L, et al. Diagnostics and treatment of infection than resort to a “shotgun approach” infectious keratitis. Orv Hetil. 2017;158:1203-1212.
Load more

Recommended publications
  • Differentiate Red Eye Disorders
    Introduction DIFFERENTIATE RED EYE DISORDERS • Needs immediate treatment • Needs treatment within a few days • Does not require treatment Introduction SUBJECTIVE EYE COMPLAINTS • Decreased vision • Pain • Redness Characterize the complaint through history and exam. Introduction TYPES OF RED EYE DISORDERS • Mechanical trauma • Chemical trauma • Inflammation/infection Introduction ETIOLOGIES OF RED EYE 1. Chemical injury 2. Angle-closure glaucoma 3. Ocular foreign body 4. Corneal abrasion 5. Uveitis 6. Conjunctivitis 7. Ocular surface disease 8. Subconjunctival hemorrhage Evaluation RED EYE: POSSIBLE CAUSES • Trauma • Chemicals • Infection • Allergy • Systemic conditions Evaluation RED EYE: CAUSE AND EFFECT Symptom Cause Itching Allergy Burning Lid disorders, dry eye Foreign body sensation Foreign body, corneal abrasion Localized lid tenderness Hordeolum, chalazion Evaluation RED EYE: CAUSE AND EFFECT (Continued) Symptom Cause Deep, intense pain Corneal abrasions, scleritis, iritis, acute glaucoma, sinusitis, etc. Photophobia Corneal abrasions, iritis, acute glaucoma Halo vision Corneal edema (acute glaucoma, uveitis) Evaluation Equipment needed to evaluate red eye Evaluation Refer red eye with vision loss to ophthalmologist for evaluation Evaluation RED EYE DISORDERS: AN ANATOMIC APPROACH • Face • Adnexa – Orbital area – Lids – Ocular movements • Globe – Conjunctiva, sclera – Anterior chamber (using slit lamp if possible) – Intraocular pressure Disorders of the Ocular Adnexa Disorders of the Ocular Adnexa Hordeolum Disorders of the Ocular
    [Show full text]
  • Onchocerciasis
    11 ONCHOCERCIASIS ADRIAN HOPKINS AND BOAKYE A. BOATIN 11.1 INTRODUCTION the infection is actually much reduced and elimination of transmission in some areas has been achieved. Differences Onchocerciasis (or river blindness) is a parasitic disease in the vectors in different regions of Africa, and differences in cause by the filarial worm, Onchocerca volvulus. Man is the the parasite between its savannah and forest forms led to only known animal reservoir. The vector is a small black fly different presentations of the disease in different areas. of the Simulium species. The black fly breeds in well- It is probable that the disease in the Americas was brought oxygenated water and is therefore mostly associated with across from Africa by infected people during the slave trade rivers where there is fast-flowing water, broken up by catar- and found different Simulium flies, but ones still able to acts or vegetation. All populations are exposed if they live transmit the disease (3). Around 500,000 people were at risk near the breeding sites and the clinical signs of the disease in the Americas in 13 different foci, although the disease has are related to the amount of exposure and the length of time recently been eliminated from some of these foci, and there is the population is exposed. In areas of high prevalence first an ambitious target of eliminating the transmission of the signs are in the skin, with chronic itching leading to infection disease in the Americas by 2012. and chronic skin changes. Blindness begins slowly with Host factors may also play a major role in the severe skin increasingly impaired vision often leading to total loss of form of the disease called Sowda, which is found mostly in vision in young adults, in their early thirties, when they northern Sudan and in Yemen.
    [Show full text]
  • Overview of Antiviral Medications Used in Ophthalmology
    ANTIVIRALS Overview of antiviral medications Jeremy Hoffman Clinical Research used in ophthalmology Fellow: International Centre for Eye Health, As eye health professionals, London School of Hygiene & Tropical we are fortunate to have Medicine, UK. a number of antiviral medications available in our armoury to treat a range of ophthalmic viral infections. This article provides an overview of what antiviral agents are available for these conditions, detailing their regimen SANDIP DAS SANYAM (SAGARMATHA CHOUDHARY EYE HOSPITAL, NEPAL) SANDIP DAS SANYAM(SAGARMATHA and evidence that Aciclovir – either as topical eye ointment or systemic tablets – is still the first-line antiviral in the treatment of many viral eye diseases around the supports their use. world, including here in Nepal. phthalmic viral infections, particularly herpes associated with toxicity, including superficial punctate simplex keratitis, have been at the forefront of keratopathy, chemical conjunctivitis, punctal occlusion Othe development of antiviral medications. and occasional serious hypersensitivity reactions. Idoxuridine was also unable to penetrate the corneal The discovery of the first targeted antiviral agent, epithelium to treat stromal or endothelial keratitis. in common with penicillin (the first antibiotic), owes much to serendipity. In 1959, William Prusoff With the advent of aciclovir in 1982, most herpetic developed idoxuridine (IDU) as a potential systemic ophthalmic infections became treatable, including anti-cancer agent. Idoxuridine those caused by herpes
    [Show full text]
  • The Pennsylvania State University
    The Pennsylvania State University The Graduate School Department of Chemistry SYNTHESIS OF NOVEL ANTIVIRAL AGENTS AND FLUORESCENT MOLECULAR PROBES A Dissertation in Chemistry by Runzhi Wu 2010 Runzhi Wu Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2010 The dissertation of Runzhi Wu was reviewed and approved* by the following: Blake R. Peterson Regents Distinguished Professor of Medicinal Chemistry University of Kansas Dissertation Advisor Special Member of Committee Raymond L. Funk Professor of Chemistry Chair of Committee Phillip C. Bevilacqua Professor of Chemistry Gong Chen Assistant Professor of Chemistry Avery August Distinguished Professor of Immunology Barbara J. Garrison Shapiro Professor of Chemistry Head of the Department of Chemistry *Signatures are on file in the Graduate School iii ABSTRACT RNA viruses cause a wide variety of diseases including SARS, influenza, hepatitis C and polio. Therapeutics for RNA virus infections are often limited because of the rapid development of antiviral drug resistance. RNA viruses are known to exhibit high error rates during replication and thus exist as quasispecies. To maintain the maximum adaptability, these viruses exist on the edge of “error catastrophe”, and small increases in the mutation frequency can cause a drastic decrease in viral infectivity. By taking advantage of the high mutation rate of RNA virus replication, a relatively new antiviral approach termed “lethal mutagenesis” can be used to increase the error rate of RNA viral replication to intolerable levels, resulting in the loss of viral viability. Chapter one of this dissertation reviews current antiviral therapeutics and lethal mutagenesis as an antiviral strategy.
    [Show full text]
  • Immune Defense at the Ocular Surface
    Eye (2003) 17, 949–956 & 2003 Nature Publishing Group All rights reserved 0950-222X/03 $25.00 www.nature.com/eye Immune defense at EK Akpek and JD Gottsch CAMBRIDGE OPHTHALMOLOGICAL SYMPOSIUM the ocular surface Abstract vertebrates. Improved visual acuity would have increased the fitness of these animals and would The ocular surface is constantly exposed to a have outweighed the disadvantage of having wide array of microorganisms. The ability of local immune cells and blood vessels at a the outer ocular system to recognize pathogens distance where a time delay in addressing a as foreign and eliminate them is critical to central corneal infection could lead to blindness. retain corneal transparency, hence The first vertebrates were jawless fish that preservation of sight. Therefore, a were believed to have evolved some 470 million combination of mechanical, anatomical, and years ago.1 These creatures had frontal eyes and immunological defense mechanisms has inhabited the shorelines of ancient oceans. With evolved to protect the outer eye. These host better vision, these creatures were likely more defense mechanisms are classified as either a active and predatory. This advantage along with native, nonspecific defense or a specifically the later development of jaws enabled bony fish acquired immunological defense requiring to flourish and establish other habitats. One previous exposure to an antigen and the such habitat was shallow waters where lunged development of specific immunity. Sight- fish made the transition to land several hundred threatening immunopathology with thousand years later.2 To become established in autologous cell damage also can take place this terrestrial environment, the new vertebrates after these reactions.
    [Show full text]
  • Trifluridine Decreases Ocular HSV-1 Recovery, but Not Herpetlc Lesions After Timolol Iontophoresis
    Investigative Ophthalmology & Visual Science, Vol. 30, No. 4, April 1989 Copyright © Association for Research in Vision and Ophthalmology Trifluridine Decreases Ocular HSV-1 Recovery, but Not Herpetlc Lesions after Timolol Iontophoresis David S. Roorman,* James M. Hill, Yasuteru Harura, James J. Reidy, and Herbert E. Kaufman To determine the effect of a topically applied antiviral agent on shedding of herpes simplex virus type 1 (HSV-1) into the tear film and corneal epithelial lesions, ten rabbits latently infected with HSV-1 were subjected to transcorneal iontophoresis of 0.01% timolol once a day for 3 consecutive days to induce viral shedding and lesions. Iontophoretic induction was performed similarly in five uninfected rabbits as controls. Half of the infected rabbits and all of the uninfected controls received topical 1.0% trifluridine five times a day for 9 days, beginning the day after the first iontophoresis. All eyes were examined daily for 10 days by slit-lamp biomicroscopy and tear film samples collected on swabs were analyzed for virus. In the infected rabbits, the eyes treated with trifluridine had significantly fewer swabs positive for HSV-1 than the untreated eyes (P < 0.001); however, there was no significant difference in the numbers of lesions in the treated and untreated eyes. The uninfected controls had no positive swabs and developed no lesions. These results suggest that topical treatment with trifluridine may reduce recovery of HSV-1 from the tear film, but does not affect the incidence of iontophoretically induced cornea! epithelial lesions. Invest Ophthalmol Vis Sci 30:678-683,1989 Herpes simplex virus type 1 (HSV-1) causes an ini- ing epinephrine iontophoresis with concomitant in- tial ocular infection followed by latency in the auto- travenous and topical acyclovir, as well as a signifi- nomic and sensory ganglia of the head and neck.1"3 cant quantitative reduction in recovery of HSV-1 Stimuli such as fever, UV radiation, stress and radial from the trigeminal ganglia.
    [Show full text]
  • Treatment of Interface Keratitis with Oral Corticosteroids
    Treatment of interface keratitis with oral corticosteroids Scott M. MacRae, MD, Larry F. Rich, MD, Damien C. Macaluso, MD ABSTRACT Purpose: To describe the results of treating interface keratitis using a combination of intensive topical and oral corticosteroids. Setting: Casey Eye Institute, Portland, Oregon, USA. Methods: Thirteen eyes treated for grade 2 to 3 interface keratitis using an oral cortico- steroid (prednisone 60 to 80 mg) as well as an hourly topical corticosteroid were retrospectively reviewed. The best corrected visual acuity (BCVA) was used as an objective guide of whether to treat with intense topical and oral corticosteroids, flap irrigation, or both. Predisposing factors such as intraoperative epithelial defects or a history of severe allergies or atopy were also looked for. Results: All 13 eyes responded favorably to the combination of intensive topical and oral corticosteroids and had a BCVA of 20/20 after the keratitis resolved. In 6 eyes (46%), the patients had a history of severe seasonal allergies. One day postoperatively, 3 eyes (23%) had an epithelial defect and 2 eyes (15%), lint particles or debris embedded in the interface. With oral corticosteroid use, 3 patients (23%) noted mild stomach irritation and 2 (15%) noted nervousness. All 5 side effects resolved without sequelae. No patient developed a serious side effect. Conclusion: A short, intense course of an oral corticosteroid was an effective treatment in patients with grade 2 or higher interface keratitis when combined with a topical corti- costeroid administered hourly. The BCVA is a helpful objective measure of the severity of interface keratitis and can be used to guide the clinician in the therapeutic strategy.
    [Show full text]
  • Frequency and Risk Factors of Symptomatic Dry Eye Disease at Tertiary Care Eye Hospital, Karachi
    Biostatistics and Biometrics Open Access Journal ISSN: 2573-2633 Research Article Biostat Biometrics Open Acc J Faisal’s Issue - January 2018 Copyright © All rights are reserved by Muhammad Faisal Fahim DOI: 10.19080/BBOAJ.2018.04.555639 Frequency and Risk Factors of Symptomatic Dry Eye Disease at Tertiary Care Eye Hospital, Karachi Shaheerah Gul1, Adil Salim Jafri1, Muhammad Faisal Fahim2* 1Department of Ophthalmology, Al-Ibrahim Eye Hospital, Pakistan 2Department of Research & Development, Al-Ibrahim Eye Hospital, Pakistan Submission: November 27, 2017; Published: January 19, 2018 *Corresponding author: Muhammad Faisal Fahim, M.Sc (Statistics), Statistician, Research & Development Department, Al-Ibrahim Eye Hospital, Isra postgraduate Institute of Ophthalmology, Karachi, Pakistan, Tel: ; Email: Abstract Objective: To determine frequency and risk factors of symptomatic dry eye disease at tertiary care eye hospital, Karachi. Material & Methods: This was a descriptive cross sectional study carried out at Al-Ibrahim Eye Hospital, Isra postgraduate Institute of Oph- thalmology, Karachi from March to October 2016. Non-Probability purposive sampling technique was used for data collection. Inclusion criteria give consent. Symptoms of dry eye were assessed using Tear breakup test (TBUT) test. SPSS version 20.0 was used to analyze data. were patients aged ≥ 21 years and on the basis of dry eye symptoms. Exclusion criteria were other systemic eye disease and those who did not Results: A total of 100 patients 65 female and 35 male were diagnosed with dry eye syndrome. The age group of 21-30 years having the high- est frequency of 34 patients, whereas after the 50 years of age the frequency of patients decreases to 21.
    [Show full text]
  • Microbial Keratitis After Corneal Collagen Crosslinking
    CASE REPORT Microbial keratitis after corneal collagen crosslinking Juan J. Pe´rez-Santonja, MD, Alberto Artola, MD, Jaime Javaloy, MD, Jorge L. Alio´, MD, PhD, Jose´L. Abad, PhD Several infiltrates appeared in the upper midperipheral cornea of a 29-year-old woman who had had uneventful corneal collagen crosslinking (CXL) with riboflavin and ultraviolet-A light (UVA) for the treatment of keratoconus in the right eye. Staphylococcus epidermidis keratitis was con- firmed by microbiological studies, which guided treatment with topical fortified antibiotic agents. Before CXL, the best spectacle-corrected visual acuity (BSCVA) in the right eye was 20/25, the manifest refraction was À0.25 À0.25 Â 125, and the anterior segment was normal under biomi- croscopy. Five months after the procedure, the BSCVA was 20/22, the manifest refraction was C1.00 À2.50 Â 40, and slitlamp examination revealed a mild residual haze in the upper midper- ipheral cornea. Collagen crosslinking with riboflavin–UVA is a minimally invasive method but tra- ditionally requires epithelial removal, which could be a predisposing factor to bacterial keratitis. J Cataract Refract Surg 2009; 35:1138–1140 Q 2009 ASCRS and ESCRS Keratoconus is a noninflammatory ectasia of the cor- light (UVA) has been developed.3 This technique in- nea that is usually bilateral. The condition typically creases the corneal rigidity of treated corneas, and pre- starts at puberty, progressing in approximately 20% liminary clinical studies have shown improvement of cases to the extent that keratoplasty is necessary.1 and stabilization of keratectasia with few, if any, com- Hard contact lenses and corneal grafting have been plications in patients with keratoconus.4,5 the major treatment modalities for keratoconus, We report a case of microbial keratitis that devel- although some patients can now benefit from intracor- oped after CXL with riboflavin and UVA for the treat- neal ring segment implantation.1,2 None of these tech- ment of keratoconus.
    [Show full text]
  • (SUNDROP): Five Years of Screening with Telemedicine
    ■ CLINICAL SCIENCE ■ Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): Five Years of Screening With Telemedicine Natalia Fijalkowski, BA; Luo Luo Zheng, BS; Michael T. Henderson, BA; Sean K. Wang, BS; Matthew B. Wallenstein, MD; Theodore Leng, MD, MS; Darius M. Moshfeghi, MD INTRODUCTION BACKGROUND AND OBJECTIVE: To report the 5-year results of the Stanford University Network for Diag- Retinopathy of prematurity (ROP) is a vision- nosis of Retinopathy of Prematurity (SUNDROP) tele- threatening disease of disordered retinal vasculature medicine initiative. development in premature and low birth weight in- fants.1,2 The underdeveloped retina overcompensates PATIENTS AND METHODS: Infants requiring retinopathy for ischemia at birth by promoting angiogenesis that of prematurity (ROP) screening at six neonatal inten- can damage nearby structures through retinal edema, sive care units from December 1, 2005, to November traction, or detachment.3,4 At United States schools, 30, 2010, were evaluated with remote retinal photogra- ROP accounts for 14% of pediatric blindness.5 The phy by an ROP specialist. Every infant received outpa- World Health Organization (WHO) found ROP to be tient binocular indirect ophthalmoscope examinations the leading cause of avoidable visual impairment in until termination criteria were achieved or until treat- high-income countries and the second leading cause ment. Outcomes were treatment-warranted ROP (TW- in middle-income countries,6 accounting for 15% to ROP, ETROP type 1) and adverse anatomical events. 35% of pediatric blindness in some nations.7-9 Randomized trials and observational studies RESULTS: Five hundred eleven infants (1,022 eyes) were demonstrate that cryotherapy,10,11 laser photocoagu- screened.
    [Show full text]
  • Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Interstitial Keratitis
    perim Ex en l & ta a l ic O p in l h Journal of Clinical & Experimental t C h f a o l m l a o Thakur et al., J Clin Exp Ophthalmol 2019, 10:2 n l o r g u y o Ophthalmology J DOI: 10.4172/2155-9570.1000797 ISSN: 2155-9570 Case Report Open Access Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Interstitial Keratitis Anchal Thakur, Amit Gupta* and Sabia Handa Department of Ophthalmology, Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India *Corresponding author: Amit Gupta, Department of Ophthalmology, Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India, Tel: 0172 274 7585; E-mail: [email protected] Received date: January 31, 2019; Accepted date: March 19, 2019; Published date: March 26, 2019 Copyright: ©2019 Thakur A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract We describe the use of subconjunctival Bevacizuamb as an adjunct in the treatment of viral interstitial keratitis in a 17-year-old boy. He presented with a 3 months history of gradually progressive diminution of vision. The presenting visual acuity was 20/120 in the right eye and counting fingers close to face in the left eye. Examination revealed bilateral disc shaped stromal edema with leash of blood vessels entering the superior quadrant of the cornea. Subconjunctival injection of 0.1 mL (2.5 mg) of commercially available Bevacizumab (100 mg/4 mL; Avastin) was given under topical anesthesia along with initiation of topical steroids in the form of Betamethasone 0.1%.
    [Show full text]
  • The Definition and Classification of Dry Eye Disease
    DEWS Definition and Classification The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry E y e W ork Shop (2 0 0 7 ) ABSTRACT The aim of the DEWS Definition and Classifica- I. INTRODUCTION tion Subcommittee was to provide a contemporary definition he Definition and Classification Subcommittee of dry eye disease, supported within a comprehensive clas- reviewed previous definitions and classification sification framework. A new definition of dry eye was devel- T schemes for dry eye, as well as the current clinical oped to reflect current understanding of the disease, and the and basic science literature that has increased and clarified committee recommended a three-part classification system. knowledge of the factors that characteriz e and contribute to The first part is etiopathogenic and illustrates the multiple dry eye. Based on its findings, the Subcommittee presents causes of dry eye. The second is mechanistic and shows how herein an updated definition of dry eye and classifications each cause of dry eye may act through a common pathway. based on etiology, mechanisms, and severity of disease. It is stressed that any form of dry eye can interact with and exacerbate other forms of dry eye, as part of a vicious circle. II. GOALS OF THE DEFINITION AND Finally, a scheme is presented, based on the severity of the CLASSIFICATION SUBCOMMITTEE dry eye disease, which is expected to provide a rational basis The goals of the DEWS Definition and Classification for therapy. These guidelines are not intended to override the Subcommittee were to develop a contemporary definition of clinical assessment and judgment of an expert clinician in dry eye disease and to develop a three-part classification of individual cases, but they should prove helpful in the conduct dry eye, based on etiology, mechanisms, and disease stage.
    [Show full text]